WallStSmart

Amrize Ltd (AMRZ)vsReTo Eco-Solutions Inc (RETO)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Amrize Ltd generates 559853% more annual revenue ($11.81B vs $2.11M). AMRZ leads profitability with a 10.0% profit margin vs 0.0%. AMRZ earns a higher WallStSmart Score of 55/100 (C-).

AMRZ

Buy

55

out of 100

Grade: C-

Growth: 3.3Profit: 6.5Value: 7.3Quality: 5.8
Piotroski: 3/9

RETO

Hold

35

out of 100

Grade: F

Growth: 5.3Profit: 2.5Value: 5.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AMRZSignificantly Overvalued (-119.3%)

Margin of Safety

-119.3%

Fair Value

$26.88

Current Price

$56.12

$29.24 premium

UndervaluedFair: $26.88Overvalued

Intrinsic value data unavailable for RETO.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AMRZ2 strengths · Avg: 8.0/10
Price/BookValuation
2.3x8/10

Reasonable price relative to book value

Free Cash FlowQuality
$1.65B8/10

Generating 1.6B in free cash flow

RETO2 strengths · Avg: 10.0/10
Price/BookValuation
0.0x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
36.6%10/10

Revenue surging 36.6% year-over-year

Areas to Watch

AMRZ4 concerns · Avg: 3.3/10
P/E RatioValuation
25.9x4/10

Moderate valuation

EPS GrowthGrowth
3.6%4/10

3.6% earnings growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Revenue GrowthGrowth
-0.4%2/10

Revenue declined 0.4%

RETO4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$9.11M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Return on EquityProfitability
-38.3%2/10

ROE of -38.3% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : AMRZ

The strongest argument for AMRZ centers on Price/Book, Free Cash Flow. PEG of 1.40 suggests the stock is reasonably priced for its growth.

Bull Case : RETO

The strongest argument for RETO centers on Price/Book, Revenue Growth. Revenue growth of 36.6% demonstrates continued momentum.

Bear Case : AMRZ

The primary concerns for AMRZ are P/E Ratio, EPS Growth, Piotroski F-Score.

Bear Case : RETO

The primary concerns for RETO are EPS Growth, Market Cap, Profit Margin.

Key Dynamics to Monitor

AMRZ profiles as a value stock while RETO is a hypergrowth play — different risk/reward profiles.

RETO is growing revenue faster at 36.6% — sustainability is the question.

AMRZ generates stronger free cash flow (1.6B), providing more financial flexibility.

Monitor BUILDING MATERIALS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

AMRZ scores higher overall (55/100 vs 35/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Amrize Ltd

BASIC MATERIALS · BUILDING MATERIALS · USA

Amrize Ltd (AMRZ) is an innovative technology company at the forefront of the digital health and wellness sector, striving to transform healthcare delivery through advanced technologies and data-driven solutions. With a strong emphasis on enhancing patient outcomes and increasing healthcare accessibility, Amrize engages in extensive research and development to address the growing demand for scalable health solutions. The company’s strategic initiatives position it to play a pivotal role in the evolving landscape of healthcare, making it a critical player in the advancement of modern healthcare systems.

Visit Website →

ReTo Eco-Solutions Inc

BASIC MATERIALS · BUILDING MATERIALS · China

ReTo Eco-Solutions, Inc. manufactures and distributes building materials primarily in China. The company is headquartered in Beijing, the People's Republic of China.

Visit Website →

Want to dig deeper into these stocks?